A Big Win for Diabetic Kidney Disease: CREDENCE-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Big Win for Diabetic Kidney Disease: CREDENCE

Published:2019-05 Issue:5 Volume:29 Page:1024-1027
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Cherney David Z.I.,Odutayo Ayodele,Verma Subodh

Funder

University of Toronto

Canadian Institutes of Health Research

Diabetes Canada

Heart and Stroke Richard Lewar Centre of Excellence

Heart and Stroke Foundation of Canada

Janssen

Boehringer Ingelheim-Eli Lilly

AstraZeneca

Merck

Amgen

Bayer Healthcare

Boehringer Ingelheim

Bristol-Myers Squibb

Eli Lilly

Novartis

Novo Nordisk

Sanofi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference15 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Lancet,2016

2. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016

3. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics;Jardine;Am. J. Nephrol.,2017

4. Empagliflozin’s fuel hypothesis: not so soon;Lopaschuk;Cell Metab.,2016

5. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors;Biomedicine & Pharmacotherapy;2023-09

2. Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews;European Journal of Integrative Medicine;2023-08

3. Visceral Adipose Tissue and Its Evaluation Index and the Research Progress of Diabetic Nephropathy;Advances in Clinical Medicine;2023

4. Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation;Experimental Gerontology;2022-10

5. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations;Kidney International Reports;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3